Cargando…
Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571703/ https://www.ncbi.nlm.nih.gov/pubmed/37841422 http://dx.doi.org/10.3389/fonc.2023.1212529 |
_version_ | 1785120063321276416 |
---|---|
author | Dou, Weidong Guan, Yu Liu, Tao Zheng, Hang Feng, Shuo Wu, Yingchao Wang, Xin Liu, Zhanbing |
author_facet | Dou, Weidong Guan, Yu Liu, Tao Zheng, Hang Feng, Shuo Wu, Yingchao Wang, Xin Liu, Zhanbing |
author_sort | Dou, Weidong |
collection | PubMed |
description | Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because of an accidental abdominal mass. Abdominal and pelvic enhanced CT revealed a tumor apparently orginated from mesenchymal tissue. Subsequently, the abdominal mass and multiple organ resection was performed, and the mass was pathologically confirmed as EIMS. The patient developed Clavien-Dindo Grade III postoperative complications and was discharged after his condition improved. He received doxorubicin monotherapy after operation, but only one cycle was administered due to severe vomiting. The follow-up of 5 months after operation showed no evidence of recurrence. Given the rarity of EIMS, and ALk inhibitors have a long and robust effect on patients with ALK gene tumors, it is very important for clinicians to be familiar with the clinicopathological features of EIMS, which will contribute to the accurate diagnosis of EIMS and reduce misdiagnosis. |
format | Online Article Text |
id | pubmed-10571703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105717032023-10-14 Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review Dou, Weidong Guan, Yu Liu, Tao Zheng, Hang Feng, Shuo Wu, Yingchao Wang, Xin Liu, Zhanbing Front Oncol Oncology Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because of an accidental abdominal mass. Abdominal and pelvic enhanced CT revealed a tumor apparently orginated from mesenchymal tissue. Subsequently, the abdominal mass and multiple organ resection was performed, and the mass was pathologically confirmed as EIMS. The patient developed Clavien-Dindo Grade III postoperative complications and was discharged after his condition improved. He received doxorubicin monotherapy after operation, but only one cycle was administered due to severe vomiting. The follow-up of 5 months after operation showed no evidence of recurrence. Given the rarity of EIMS, and ALk inhibitors have a long and robust effect on patients with ALK gene tumors, it is very important for clinicians to be familiar with the clinicopathological features of EIMS, which will contribute to the accurate diagnosis of EIMS and reduce misdiagnosis. Frontiers Media S.A. 2023-09-29 /pmc/articles/PMC10571703/ /pubmed/37841422 http://dx.doi.org/10.3389/fonc.2023.1212529 Text en Copyright © 2023 Dou, Guan, Liu, Zheng, Feng, Wu, Wang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Dou, Weidong Guan, Yu Liu, Tao Zheng, Hang Feng, Shuo Wu, Yingchao Wang, Xin Liu, Zhanbing Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title | Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title_full | Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title_fullStr | Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title_full_unstemmed | Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title_short | Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
title_sort | epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571703/ https://www.ncbi.nlm.nih.gov/pubmed/37841422 http://dx.doi.org/10.3389/fonc.2023.1212529 |
work_keys_str_mv | AT douweidong epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT guanyu epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT liutao epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT zhenghang epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT fengshuo epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT wuyingchao epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT wangxin epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview AT liuzhanbing epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview |